Issue 1/2020
Content (21 Articles)
Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies
Chin-Hsing Annie Lin, Mitchel S. Berger
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma
Anne Berberich, Lara-Marie Schmitt, Stefan Pusch, Thomas Hielscher, Petra Rübmann, Nanina Hucke, Pauline Latzer, Bernd Heßling, Dieter Lemke, Tobias Kessler, Michael Platten, Wolfgang Wick
Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas
Keshav Karki, Xi Li, Un-Ho Jin, Kumaravel Mohankumar, Mahsa Zarei, Sharon K. Michelhaugh, Sandeep Mittal, Ronald Tjalkens, Stephen Safe
Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma
Kok-Siong Chen, Caitlin R. Bridges, Zorana Lynton, Jonathan W. C. Lim, Brett W. Stringer, Revathi Rajagopal, Kum-Thong Wong, Dharmendra Ganesan, Hany Ariffin, Bryan W. Day, Linda J. Richards, Jens Bunt
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study
H. Pinson, G. Hallaert, J. Van der Meulen, F. Dedeurwaerdere, D. Vanhauwaert, C. Van den Broecke, J. Van Dorpe, D. Van Roost, J. P. Kalala, T. Boterberg
Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation
Claudia Baumann, Julia Tichy, Jan Hendrik Schaefer, Joachim P. Steinbach, Michel Mittelbronn, Marlies Wagner, Christian Foerch
Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy
Paula Alcaide-Leon, Tracy L. Luks, Marisa Lafontaine, Janine M. Lupo, Hideho Okada, Jennifer L. Clarke, Javier E. Villanueva-Meyer
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Martin van den Bent, Analia Azaro, Filip De Vos, Juan Sepulveda, W. K. Alfred Yung, Patrick Y. Wen, Andrew B. Lassman, Markus Joerger, Ghazaleh Tabatabai, Jordi Rodon, Ralph Tiedt, Sylvia Zhao, Tiina Kirsilae, Yi Cheng, Sergio Vicente, O. Alejandro Balbin, Hefei Zhang, Wolfgang Wick
Hypofractionated radiotherapy with temozolomide in diffuse intrinsic pontine gliomas: a randomized controlled trial
Yousra Izzuddeen, Subhash Gupta, K. P. Haresh, Dayanand Sharma, Prashanth Giridhar, Gour Kishore Rath
Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study
Emma van Kessel, Tom J. Snijders, Anniek E. Baumfalk, Carla Ruis, Kirsten M. van Baarsen, Marike L. Broekman, Martine J. E. van Zandvoort, Pierre A. Robe
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study
Michael A. Mooney, Wenya Linda Bi, Jonathan M. Cantalino, Kyle C. Wu, Thomas C. Harris, Lucas L. Possatti, Parikshit Juvekar, Liangge Hsu, Ian F. Dunn, Ossama Al-Mefty, Phillip M. Devlin
A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy
Alexander J. Lin, Liam T. Kane, Jason K. Molitoris, Deborah R. Smith, Sonika Dahiya, Shahed N. Badiyan, Tony J. C. Wang, Tim J. Kruser, Jiayi Huang
Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial
Roshan Karunamuni, Kathryn R. Tringale, Jeffrey Burkeen, Michelle D. Tibbs, Minh-Phuong Huynh-Le, Naeim Bahrami, Deborah Marshall, Tyler M. Seibert, Carrie R. McDonald, Jona A. Hattangadi-Gluth
Tumor immune microenvironment is associated with the growth of intracranial germinomas
Masaaki Nishimoto, Kentaro Ohara, Dai Kamamoto, Ryota Tamura, Tomoru Miwa, Kazunari Yoshida, Hikaru Sasaki
Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor
Andrew M. Heitzer, Alexandra M. Villagran, Kimberly Raghubar, Austin L. Brown, Miranda L. Camet, M. Douglas Ris, Jenny H. Hanning, M. Fatih Okcu, Arnold C. Paulino, Murali Chintagumpala, Lisa S. Kahalley
Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients
Aaron Michael Rulseh, Josef Vymazal
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival
Lauren R. Schaff, Dongyao Yan, Sheeno Thyparambil, Yuan Tian, Fabiola Cecchi, Marc Rosenblum, Anne S. Reiner, Katherine S. Panageas, Todd Hembrough, Andrew L. Lin
Patterns of seizure prophylaxis after oncologic neurosurgery
Brett E. Youngerman, Evan F. Joiner, Xianling Wang, Jingyan Yang, Mary R. Welch, Guy M. McKhann II, Jason D. Wright, Dawn L. Hershman, Alfred I. Neugut, Jeffrey N. Bruce
The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study
Filipe Martins, Luis Schiappacasse, Marc Levivier, Constantin Tuleasca, Michel A. Cuendet, Veronica Aedo-Lopez, Bianca Gautron Moura, Krisztian Homicsko, Adrienne Bettini, Gregoire Berthod, Camille L. Gérard, Alexandre Wicky, Jean Bourhis, Olivier Michielin
Preoperative predictive factors affecting return to work in patients with gliomas undergoing awake brain mapping
Akihito Yoshida, Kazuya Motomura, Atsushi Natsume, Lushun Chalise, Kentaro Iijima, Daisuke Hara, Izumi Kadono, Kenji Wakai, Toshihiko Wakabayashi
Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas
Lai-Rong Song, Jian-Cong Weng, Xu-Lei Huo, Liang Wang, Huan Li, Da Li, Zhen Wu, Jun-Ting Zhang